HomeORGANIZATION
ORGANIZATION

Value of Pharmaceutical Innovation Should Be Fully Recognized: PhRMA CEO
(Sep.30.2016)

PhRMA President and CEO Stephen J. Ubl
Japanese policymakers should fully recognize the value of pharmaceutical innovation when they craft the country’s reimbursement system by looking at the “residual value” that occurs through effective prevention and treatments, PhRMA President and CEO Stephen J. Ubl said at a Tokyo press conference ...
(LOG IN FOR FULL STORY)

News Calendar